Expert Opinion

Riluzole 5 mg/mL oral suspension: for optimized drug delivery in amyotrophic lateral sclerosis

Dyer AM, Smith A

Drug Design, Development and Therapy 2017, 11:59-64

Published Date: 22 December 2016